Study on risk factors and outcomes in patients with tricuspid regurgitation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter cohort study focuses on patients diagnosed with tricuspid regurgitation during hospitalization. It aims to evaluate prognostic risk factors associated with this condition and construct predictive models based on follow-up observations. The primary outcome is all-cause mortality, while secondary outcomes include cardiovascular events. The study will gather data from multiple hospitals to enhance the understanding of tricuspid regurgitation outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Aged over 18 yrs.
* Patients diagnosed with tricuspid regurgitation during hospitalization.

Exclusion Criteria:

* Patients unable to provide informed consent.

Where it's running

• The First Affiliated Hospital of Sun Yat-sen Univerity
  Guangzhou, Guangdong, China Recruiting
• Third Affiliated Hospital, Sun Yat-Sun University,
  Guangzhou, Guangdong, China Active not recruiting
• Jieyang People's Hospital
  Jieyang, Guangdong, China Active not recruiting
• Second Affiliated Hospital of Shantou University Medical College
  Shantou, Guangdong, China Active not recruiting
• Eighth Affiliated Hospital, Sun Yat-Sen University
  Shenzhen, Guangdong, China Active not recruiting
• Affiliated Hospital of Guangdong Medical University
  Zhanjiang, Guangdong, China Active not recruiting

Study contacts

• Study coordinator: Xiaodong Zhuang
• Email: zhuangxd3@mail.sysu.edu.cn
• Phone: +8613760755035

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 3D Echocardiography to See How CIEDs May Worsen Tricuspid Regurgitation

  This study tests whether different CIEDs (leadless pacemakers, LBBaP, and conventional pacemakers) differ in causing worsening tricuspid regurgitation, using 3D heart imaging.

  Recruiting Samsung Medical Center · Seoul, Seoul · NCT07793916

• Compare leadless and left bundle branch pacemakers for heart and valve function

  This study tests whether leadless pacemakers or left bundle branch area pacing better preserve heart and tricuspid valve function in adults needing a pacemaker.

  Recruiting Guy's and St Thomas' NHS Foundation Trust · London · NCT07534917

• TriClip for treating tricuspid regurgitation in Japan

  This study will see if the TriClip device is safe and helps people in Japan with symptomatic severe tricuspid regurgitation when used in routine clinical care.

  Recruiting Abbott Medical Devices · Suita, Osaka · NCT07509658

• Impact of transcatheter tricuspid valve repair on kidneys, strength, and activity in older adults

  This study will try catheter-based tricuspid valve repair (TEER) in older adults with severe symptomatic tricuspid regurgitation to see if kidney function, fluid overload, and physical activity improve.

  Recruiting Robert Bosch Medical Center · Stuttgart · NCT07464106

• TARGET 2.0: Cardiovalve TR replacement for tricuspid regurgitation

  This study will test a percutaneously delivered Cardiovalve tricuspid replacement via the femoral vein in adults with symptomatic severe secondary tricuspid regurgitation who are high risk for open-heart surgery.

  Recruiting Cardiovalve Ltd. · Bonn · NCT07334691

• Pivot Extend device to treat severe tricuspid regurgitation

  This trial will try the Pivot Extend device in adults with severe, symptomatic tricuspid regurgitation to see if it safely reduces valve leakage and improves symptoms.

  Recruiting Tau-MEDICAL Co., Ltd. · Macquarie Park, New South Wales · NCT07172477

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.